Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated guinea pig papillary muscle

General Pharmacology

Volumn 29, Issue 2, 1997, Pages 275-280

  Pankucsi, Csaba ^a   Bányász, Tamás ^a   Magyar, János ^a   Gyönös, Ildikó ^b   Kovâcs, Anikó ^b   Szénâsi, Gábor ^b   Varró, András ^c   Nánási, Péter P ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Action potential duration; Antiarrhythmic drug; Cardiac muscle; Electrophysiology; Use dependence

Indexed keywords

5 CHLORO 4 [3 [N [2 (3,4 DIMETHOXYPHENYL)ETHYL] N METHYLAMINO]PROPYLAMINO] 3(2H) PYRIDAZINONE; ANTIARRHYTHMIC AGENT; UNCLASSIFIED DRUG; PYRIDAZINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GUINEA PIG; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART PACING; HEART PAPILLARY MUSCLE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; ACTION POTENTIAL; ANIMAL; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; PHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; PAPILLARY MUSCLES; PYRIDAZINES;

EID: 0342710361     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00461-2     Document Type: Article

References (18)

1. Attwell D., Cohen I., Eisner D., Ohba M. and Ojeda C. (1979) The steady-state TTX-sensitive ("window") sodium current in cardiac Purkinje fibers. Pflügers Arch. 379, 137-142.
2. max) in guinea-pig ventricular action potentials by mexiletine, disopyramide and encainide. J. Cardiovasc. Pharmac. 5, 291-296.
3. Campbell T. J. (1983b) Kinetics of onset of rate-dependent effects of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc. Res. 17, 344-352.
4. Campbell T. J. (1983c) Importance of physico-chemical properties in determining the kinetics of the effects of class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br. J. Pharmac. 80, 33-40.
5. Hondeghem L. M. and Katzung B. G. (1984) Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu. Rev. Pharmac. Toxic. 24, 387-423.
6. Kus T. and Sasyniuk B. I. (1978) The electrophysiological effects of disopyramide on canine ventricular muscle and Purkinje fibers in normal and low potassium. Can. J. Physiol. Pharmac. 56, 139-149.
7. Matsuda H. and Noma A. (1984) Isolation of calcium current and its sensitivity to monovalent cations in dialysed ventricular cells of guinea-pig. J. Physiol. 357, 553-573.
8. McVay M. R., Natarajan G., Reddy C. P. and Surawicz B. (1982) Idiopathic long QT syndrome: association of VT with alternating left and right bundle branch block. J. Electrocardiol. 15, 189-194.
9. Nattel S. and Zeng F. D. (1984) Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers. J. Pharmac. Exp. Ther. 229, 283-291.
10. Protiva M. (1993) Meeting report of the 14th International Congress of Heterocyclic Chemistry and 11th Symposium on Chemistry of Heterocyclic Compounds. Drugs Future 18, 1143-1150.
11. Rosen M. R., Merker C., Gelband H. and Hoffman B. F. (1973) Effects of procaine amide on the electrophysiological properties of the canine ventricular conducting system. J. Pharmac. Exp. Ther. 185, 438-446.
12. + current: differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96, 195-214.
13. Sokal R. R. and Rohlf F. J. (1969) Estimation and hypothesis testing. In Biometry, pp. 127-174. Freeman, San Francisco.
14. Tritthart H., Fleckenstein B. and Fleckenstein A. (1971) Some fundamental actions of antiarrhythmic drugs on the excitability and contractility of single myocardial fibers. Naunyn-Schmiedberg's Arch. Pharmac. 269, 212-219.
15. Varró A., Elharrar V. and Surawicz B. (1985) Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers. J. Pharmac. Exp. Ther. 233, 304-311.
16. Varró A., Nakaya Y., Elharrar V. and Surawicz B. (1986) Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers. J. Cardiovasc. Pharmac. 8, 178-185.
17. Vaughan Williams E. M. (1975) Classification of antidysrhythmic drugs. Pharmac. Ther. B 1, 115-138.
18. Vaughan Williams E. M. (1984) Subgroups of class I antiarrhythmic drugs. Eur. Heart J. 5, 96-98.